Page last updated: 2024-09-05

zm 241385 and Cancer of Cervix

zm 241385 has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ávila-Ibarra, LR; de Lourdes Mora-García, M; Del Carmen Fuentes-Castañeda, M; Don-López, CA; García-Rocha, R; Gutiérrez-Serrano, V; Hernández-Montes, J; Monroy-García, A; Torres-Pineda, DB; Weiss-Steider, B	1

Other Studies

1 other study(ies) available for zm 241385 and Cancer of Cervix

Article	Year
Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1. Cytokine, 2019, Volume: 118 Topics: 5'-Nucleotidase; Acetamides; Adenosine; Adenosine A2 Receptor Antagonists; Autocrine Communication; Cell Line, Tumor; Female; GPI-Linked Proteins; HeLa Cells; Humans; Immunosuppression Therapy; Purines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Transforming Growth Factor beta1; Triazines; Triazoles; Tumor Microenvironment; Uterine Cervical Neoplasms	2019

Article

Year

Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1.

Cytokine, 2019, Volume: 118

Topics: 5'-Nucleotidase; Acetamides; Adenosine; Adenosine A2 Receptor Antagonists; Autocrine Communication; Cell Line, Tumor; Female; GPI-Linked Proteins; HeLa Cells; Humans; Immunosuppression Therapy; Purines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Transforming Growth Factor beta1; Triazines; Triazoles; Tumor Microenvironment; Uterine Cervical Neoplasms

2019